Related Experiment Video
Updated: Jan 24, 2026

BtM, a Low-cost Open-source Datalogger to Estimate the Water Content of Nonvascular Cryptogams
Published on: March 25, 2019
An evidence-based model to consolidate medication adherence cost estimation: the medication adherence cost estimation
Rachelle L Cutler1, Naomi Van der Linden2, Shalom I Charlie Benrimoj3
1Graduate School of Health, University of Technology Sydney, Sydney, Australia, 2007.
Abstract:
Aim: To develop a standardized framework determining the economic impact of medication nonadherence. Materials & methods: Secondary analysis of existing literature reported cost data, aggregating cost outcome indicators. Weighted-average cost analysis performed, determining the proportional contribution to total cost. Results: Direct costs were reported in 92% of studies and indirect costs in 4% of studies. Three most utilized cost categories were hospital (68%), primary care (18%) and pharmacy costs (72%). Average unadjusted direct costs ranged from $625 to $154,203 contributing to 88% of the total cost; adjusted medical costs ranged from $565 to $56,313 representing 96% of the total cost. Conclusion: The medication adherence cost estimation framework enables the comparison of costing studies, facilitating informed health policy decision-making based on consistent evidence and terminology.
Related Concept Videos
What are Estimates?
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
Inhaled Medications
Estimation of k and VD of Aminoglycosides
Estimation of the Physical Quantities
The Evidence for Evolution
Endocarditis III: Medical Management

